STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENTO
  4. [SEC STAFF ACTION] Entero Therapeutics, Inc. SEC Filing

[SEC STAFF ACTION] Entero Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SEC STAFF ACTION
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.
SEC STAFF ACTION - Entero Therapeutics, Inc.

SEC STAFF ACTION Filing - Entero Therapeutics, Inc.

This filing is available as a PDF document.

Filing Type: SEC STAFF ACTION

Company: Entero Therapeutics, Inc. (ENTO)

Acceptance Date: 2025-09-26T10:00:03.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock ENTO logo
Entero Therapeutics

NASDAQ:ENTO

ENTO Rankings

#6296 Ranked by Market Cap
N/A Ranked by Dividends
#68 Top Loser

ENTO Latest News

Oct 1, 2025
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
Aug 14, 2025
Entero Therapeutics, Inc. Announces Reverse Stock Split
Aug 11, 2025
Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules
Mar 24, 2025
Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC
Feb 14, 2025
Entero Therapeutics Appoints Richard Paolone as CEO

ENTO Latest SEC Filings

Sep 10, 2025
[S-1/A] First Wave BioPharma, Inc. Common Stock Amends IPO Registration Statement
Sep 10, 2025
[S-1/A] First Wave BioPharma, Inc. Common Stock Amends IPO Registration Statement
Sep 10, 2025
[S-1/A] First Wave BioPharma, Inc. Common Stock Amends IPO Registration Statement

ENTO Stock Data

7.88M
1.47M
7.3%
2.56%
1.75%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOCA RATON